TIMI Study Group
Rose Hamershock is a Senior Data Analyst at the Children's Hospital of Philadelphia, currently holding the position of Lead Biostatistician at the TIMI Study Group. With past experience as a Biostatistician at various hospitals and as a Research Assistant at Boston University, Rose is highly skilled in the field of biostatistics. Rose also has a strong educational background with a Bachelor of Science in Mathematics from Muhlenberg College and a Masters of Arts in Biostatistics from Boston University.
This person is not in the org chart
This person is not in any offices
TIMI Study Group
Since its inception in 1984, the TIMI Study Group has been an Academic Research Organization dedicated to advancing the knowledge and care of patients suffering from cardiovascular disease. We have led a wide array of trials, from phase I to phase IV, enrolling from less than 30 to more than 26,000 subjects, and with both industry and NIH support. Trials have been conducted in over 50 countries and at more than 5000 separate sites. We investigate a broad array of therapeutic interventions in individuals across the spectrum of cardiovascular disease, ranging from prevention in those with risk factors, to emergent interventions in those with acute manifestations of disease. In addition, we have used our large database of clinical findings, biomarkers, and genotypes to enhance the understanding of cardiovascular disease and its risk factors. By leading large-scale, international, randomized controlled trials of novel therapeutics and performing sophisticated analyses, we have been privileged to help shape the very practice of cardiovascular medicine for over a quarter of a century.